SANTARPIA, Mariacarmela
SANTARPIA, Mariacarmela
Dipartimento di Patologia Umana dell'adulto e dell'età evolutiva "Gaetano Barresi"
'Why is survival with triple negative breast cancer so low? insights and talking points from preclinical and clinical research'
2022-01-01 Passalacqua, Maria Ilenia; Rizzo, Graziella; Santarpia, Mariacarmela; Curigliano, Giuseppe
5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer
2018-01-01 Toffalorio, Francesca; Santarpia, Mariacarmela; Radice, Davide; Jaramillo, Christopher Adrian; Spitaleri, Gianluca; Manzotti, Michela; Catania, Chiara; Jordheim, Lars Petter; Pelosi, Giuseppe; Peters, Godefridus J.; Tibaldi, Carmelo; Funel, Niccola; Spaggiari, Lorenzo; de Braud, Filippo; De Pas, Tommaso; Giovannetti, Elisa
A friendly approach to pesonalized treatment in lung adenocarcinoma. REVISTA COLOMBIANA DE HEMATOLOGÍA Y ONCOLOGÍA
2012-01-01 R., Rosell; A. F., Cardona Zorrilla; R., Garcia Campelo; M., Majem; E., Carcereny; S., Viteri; A., Gascò; C., Buges; Santarpia, Mariacarmela; J., Wei; B., Massuti; C., Costa; M. A., Molina
A multicenter-retrospective study of non-small-cell lung carcinoma harboring uncommon epidermal growth factor receptor (EGFR) mutations: different subtypes of EGFR exon 19 deletion-insertions exhibit the clinical characteristics and prognosis of non-small cell lung carcinoma
2022-01-01 Chen, Ying; Xu, Jinhe; Zhang, Lei; Song, Yingfang; Wen, Wen; Lu, Jun; Zhao, Zhongquan; Kong, Wencui; Liu, Wei; Guo, Aiping; Santarpia, Mariacarmela; Yamada, Tadaaki; Cai, Xiuyu; Yu, Zongyang
A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations
2021-01-01 Santarpia, M.; Massafra, M.; Gebbia, V.; D'Aquino, A.; Garipoli, C.; Altavilla, G.; Rosell, R.
Activation of viral defense signaling in cancer
2018-01-01 Gonzalez-Cao, M; Karachaliou, N; Santarpia, M; Viteri, S; Meyerhans, A; Rosell, R.
Adaptive Resistance Mechanisms in EGFR Mutant NSCLC
2019-01-01 Santarpia, Mariacarmela; Karachaliou, Niki; Filipska, Martyna; Mayo-de-las-Casas, Clara; Lazzari, Chiara; Gonzalez-Cao, Maria; Rafael Rosell, And
Advances in immunotherapy for treatment of lung cancer
2015-01-01 Bustamante Alvarez, Jean G; González Cao, María; Karachaliou, Niki; Santarpia, Mariacarmela; Viteri, Santiago; Teixidó, Cristina; Rosell, Rafael
Age-related genetic abnormalities: the Achilles’ heel for customizing therapy in elderly lung cancer patients
2007-01-01 Rosell, R; Santarpia, Mariacarmela; Moran, T; Salazar M., F; Kaen D., L; Ramirez, J. L.
Alectinib: A selective, next-generation ALK inhibitor for treatment of ALK-rearranged non-small-cell lung cancer
2015-01-01 Santarpia, Mariacarmela; Altavilla, Giuseppe; Rosell, Rafael
Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway
2017-01-01 Taverna, Simona; Pucci, Marzia; Giallombardo, Marco; Di Bella, Maria Antonietta; Santarpia, Mariacarmela; Reclusa, Pablo; Gil Bazo, Ignacio; Rolfo, Christian; Alessandro, Riccardo
Amplification and overexpression of the PSMB5 gene contributes to bortezomib resistance in retreatment of patients with multiple myeloma.
2009-01-01 Altavilla, Giuseppe; Arrigo, Carmela; Marabello, Grazia; Galletti, Giuseppe; Santarpia, Mariacarmela; Sauta, Maria Grazia; Pitini, Vincenzo
An exploration of the clinical progression models of osimertinib in the treatment of advanced EGFR-mutant non-small cell lung cancer
2022-01-01 Shi, Yue; Jiang, Yingying; Pan, Banzhou; Wang, Zihan; Li, Hang; Ma, Yuxin; Liu, Yilin; He, Kang; Wang, Zhitong; Lu, Jianwei; Shi, Meiqi; Shen, Bo; Zhou, Guoren; Yin, Rong; Rossi, Antonio; Ito, Kentaro; Santarpia, Mariacarmela; Um, Sang-Won; Wang, Xiaohua; Chen, Cheng; Feng, Jifeng
Anaplastic lymphoma kinase inhibitors in phase I and phase II clinical trials for non-small cell lung cancer
2017-01-01 Karachaliou, Niki; Santarpia, Mariacarmela; Gonzalez Cao, Maria; Teixido, Cristina; Sosa, Aaron E.; Berenguer, Jordi; Rodriguez Capote, Alejandra; Altavilla, Giuseppe; Rosell, Rafael
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC)
2021-01-01 Zito, Concetta; Manganaro, Roberta; Cusmà Piccione, Maurizio; Madonna, Rosalinda; Monte, Ines; Novo, Giuseppina; Mercurio, Valentina; Longobardo, Luca; Cadeddu Dessalvi, Christian; Deidda, Martino; Pagliaro, Pasquale; Spallarossa, Paolo; Costantino, Rossella; Santarpia, Mariacarmela; Altavilla, Giuseppe; Carerj, Scipione; Tocchetti, Carlo Gabriele
Applications of genomics in NSCLC
2005-01-01 ROSELL R; COBO M; ISLA D; SANCHEZ JM; TARON M; ALTAVILLA G.; SANTARPIA M; MORAN T; CATOT S; ETXANIZ O.
Association between XPD 312 single nucleotide polymorphism (SNP) and clinical outcome in stage IIIA-B non-small-cell lung cancer (NSCLC) patients (P) < 59 years (Y) treated with chemotherapy followed by surgery
2007-01-01 Santarpia, Mariacarmela; Garrido, Pilar; Taron, Miquel; Sanchez Ronco, Maria; Pitini, Vincenzo; Rosell, Rafael; Altavilla, Giuseppe
Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy
2017-01-01 Lucchesi, Simona; Marciano', Ilaria; Paolo, Panagia; Intelisano, Rosanna; Maria Pia Randazzo, ; Sgroi, Carmela; Altavilla, Giuseppe; Santarpia, Mariacarmela; Adamo, Vincenzo; Franchina, Tindara; Francesco, Ferraù; Paolina, Reitano; Trifiro', Gianluca
Beyond platinum treatment for NSCLC: what does the future hold?
2017-01-01 Santarpia, Mariacarmela; Karachaliou, Niki; Rosell, Rafael
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer
2015-01-01 Karachaliou, Niki; Codony Servat, Jordi; Teixidó, Cristina; Pilotto, Sara; Drozdowskyj, Ana; Codony Servat, Carles; Giménez Capitán, Ana; Molina Vila, Miguel Angel; Bertrán Alamillo, Jordi; Gervais, Radj; Massuti, Bartomeu; Morán, Teresa; Majem, Margarita; Felip, Enriqueta; Carcereny, Enric; García Campelo, Rosario; Viteri, Santiago; González Cao, María; Morales Espinosa, Daniela; Verlicchi, Alberto; Crisetti, Elisabetta; Chaib, Imane; Santarpia, Mariacarmela; Luis Ramírez, José; Bosch Barrera, Joaquim; Felipe Cardona, Andrés; De Marinis, Filippo; López Vivanco, Guillermo; Miguel Sánchez, José; Vergnenegre, Alain; Sánchez Hernández, José Javier; Sperduti, Isabella; Bria, Emilio; Rosell, Rafael
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 'Why is survival with triple negative breast cancer so low? insights and talking points from preclinical and clinical research' | 1-gen-2022 | Passalacqua, Maria Ilenia; Rizzo, Graziella; Santarpia, Mariacarmela; Curigliano, Giuseppe | |
| 5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer | 1-gen-2018 | Toffalorio, Francesca; Santarpia, Mariacarmela; Radice, Davide; Jaramillo, Christopher Adrian; Spitaleri, Gianluca; Manzotti, Michela; Catania, Chiara; Jordheim, Lars Petter; Pelosi, Giuseppe; Peters, Godefridus J.; Tibaldi, Carmelo; Funel, Niccola; Spaggiari, Lorenzo; de Braud, Filippo; De Pas, Tommaso; Giovannetti, Elisa | |
| A friendly approach to pesonalized treatment in lung adenocarcinoma. REVISTA COLOMBIANA DE HEMATOLOGÍA Y ONCOLOGÍA | 1-gen-2012 | R., Rosell; A. F., Cardona Zorrilla; R., Garcia Campelo; M., Majem; E., Carcereny; S., Viteri; A., Gascò; C., Buges; Santarpia, Mariacarmela; J., Wei; B., Massuti; C., Costa; M. A., Molina | |
| A multicenter-retrospective study of non-small-cell lung carcinoma harboring uncommon epidermal growth factor receptor (EGFR) mutations: different subtypes of EGFR exon 19 deletion-insertions exhibit the clinical characteristics and prognosis of non-small cell lung carcinoma | 1-gen-2022 | Chen, Ying; Xu, Jinhe; Zhang, Lei; Song, Yingfang; Wen, Wen; Lu, Jun; Zhao, Zhongquan; Kong, Wencui; Liu, Wei; Guo, Aiping; Santarpia, Mariacarmela; Yamada, Tadaaki; Cai, Xiuyu; Yu, Zongyang | |
| A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations | 1-gen-2021 | Santarpia, M.; Massafra, M.; Gebbia, V.; D'Aquino, A.; Garipoli, C.; Altavilla, G.; Rosell, R. | |
| Activation of viral defense signaling in cancer | 1-gen-2018 | Gonzalez-Cao, M; Karachaliou, N; Santarpia, M; Viteri, S; Meyerhans, A; Rosell, R. | |
| Adaptive Resistance Mechanisms in EGFR Mutant NSCLC | 1-gen-2019 | Santarpia, Mariacarmela; Karachaliou, Niki; Filipska, Martyna; Mayo-de-las-Casas, Clara; Lazzari, Chiara; Gonzalez-Cao, Maria; Rafael Rosell, And | |
| Advances in immunotherapy for treatment of lung cancer | 1-gen-2015 | Bustamante Alvarez, Jean G; González Cao, María; Karachaliou, Niki; Santarpia, Mariacarmela; Viteri, Santiago; Teixidó, Cristina; Rosell, Rafael | |
| Age-related genetic abnormalities: the Achilles’ heel for customizing therapy in elderly lung cancer patients | 1-gen-2007 | Rosell, R; Santarpia, Mariacarmela; Moran, T; Salazar M., F; Kaen D., L; Ramirez, J. L. | |
| Alectinib: A selective, next-generation ALK inhibitor for treatment of ALK-rearranged non-small-cell lung cancer | 1-gen-2015 | Santarpia, Mariacarmela; Altavilla, Giuseppe; Rosell, Rafael | |
| Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway | 1-gen-2017 | Taverna, Simona; Pucci, Marzia; Giallombardo, Marco; Di Bella, Maria Antonietta; Santarpia, Mariacarmela; Reclusa, Pablo; Gil Bazo, Ignacio; Rolfo, Christian; Alessandro, Riccardo | |
| Amplification and overexpression of the PSMB5 gene contributes to bortezomib resistance in retreatment of patients with multiple myeloma. | 1-gen-2009 | Altavilla, Giuseppe; Arrigo, Carmela; Marabello, Grazia; Galletti, Giuseppe; Santarpia, Mariacarmela; Sauta, Maria Grazia; Pitini, Vincenzo | |
| An exploration of the clinical progression models of osimertinib in the treatment of advanced EGFR-mutant non-small cell lung cancer | 1-gen-2022 | Shi, Yue; Jiang, Yingying; Pan, Banzhou; Wang, Zihan; Li, Hang; Ma, Yuxin; Liu, Yilin; He, Kang; Wang, Zhitong; Lu, Jianwei; Shi, Meiqi; Shen, Bo; Zhou, Guoren; Yin, Rong; Rossi, Antonio; Ito, Kentaro; Santarpia, Mariacarmela; Um, Sang-Won; Wang, Xiaohua; Chen, Cheng; Feng, Jifeng | |
| Anaplastic lymphoma kinase inhibitors in phase I and phase II clinical trials for non-small cell lung cancer | 1-gen-2017 | Karachaliou, Niki; Santarpia, Mariacarmela; Gonzalez Cao, Maria; Teixido, Cristina; Sosa, Aaron E.; Berenguer, Jordi; Rodriguez Capote, Alejandra; Altavilla, Giuseppe; Rosell, Rafael | |
| Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC) | 1-gen-2021 | Zito, Concetta; Manganaro, Roberta; Cusmà Piccione, Maurizio; Madonna, Rosalinda; Monte, Ines; Novo, Giuseppina; Mercurio, Valentina; Longobardo, Luca; Cadeddu Dessalvi, Christian; Deidda, Martino; Pagliaro, Pasquale; Spallarossa, Paolo; Costantino, Rossella; Santarpia, Mariacarmela; Altavilla, Giuseppe; Carerj, Scipione; Tocchetti, Carlo Gabriele | |
| Applications of genomics in NSCLC | 1-gen-2005 | ROSELL R; COBO M; ISLA D; SANCHEZ JM; TARON M; ALTAVILLA G.; SANTARPIA M; MORAN T; CATOT S; ETXANIZ O. | |
| Association between XPD 312 single nucleotide polymorphism (SNP) and clinical outcome in stage IIIA-B non-small-cell lung cancer (NSCLC) patients (P) < 59 years (Y) treated with chemotherapy followed by surgery | 1-gen-2007 | Santarpia, Mariacarmela; Garrido, Pilar; Taron, Miquel; Sanchez Ronco, Maria; Pitini, Vincenzo; Rosell, Rafael; Altavilla, Giuseppe | |
| Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy | 1-gen-2017 | Lucchesi, Simona; Marciano', Ilaria; Paolo, Panagia; Intelisano, Rosanna; Maria Pia Randazzo, ; Sgroi, Carmela; Altavilla, Giuseppe; Santarpia, Mariacarmela; Adamo, Vincenzo; Franchina, Tindara; Francesco, Ferraù; Paolina, Reitano; Trifiro', Gianluca | |
| Beyond platinum treatment for NSCLC: what does the future hold? | 1-gen-2017 | Santarpia, Mariacarmela; Karachaliou, Niki; Rosell, Rafael | |
| BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer | 1-gen-2015 | Karachaliou, Niki; Codony Servat, Jordi; Teixidó, Cristina; Pilotto, Sara; Drozdowskyj, Ana; Codony Servat, Carles; Giménez Capitán, Ana; Molina Vila, Miguel Angel; Bertrán Alamillo, Jordi; Gervais, Radj; Massuti, Bartomeu; Morán, Teresa; Majem, Margarita; Felip, Enriqueta; Carcereny, Enric; García Campelo, Rosario; Viteri, Santiago; González Cao, María; Morales Espinosa, Daniela; Verlicchi, Alberto; Crisetti, Elisabetta; Chaib, Imane; Santarpia, Mariacarmela; Luis Ramírez, José; Bosch Barrera, Joaquim; Felipe Cardona, Andrés; De Marinis, Filippo; López Vivanco, Guillermo; Miguel Sánchez, José; Vergnenegre, Alain; Sánchez Hernández, José Javier; Sperduti, Isabella; Bria, Emilio; Rosell, Rafael |